What Is Really Driving High Prescription Drug Costs and What Can Congress and the Administration Do to Rein Them In?

Monday, February 26, 2018

1:00 p.m. E.T.

Agenda

1:00 – 1:05 p.m.
Introduction: Shawn Bishop, Vice President, Controlling Health Care Costs and Advancing Medicare, The Commonwealth Fund

1:05 – 1:10 p.m.
Bill Corr, Senior Advisor, Waxman Strategies, Deputy Secretary of Health and Human Services

1:10 – 1:15 p.m.
Charles Phelps, University Professor and Provost Emeritus, University of Rochester, and National Academy of Medicine Committee Member on Ensuring Patient Access to Affordable Drug Therapies

1:15 – 1:20 p.m.
The Honorable Henry Waxman, Chairman, Waxman Strategies, former Chairman and Ranking Member of the U.S. House Energy and Commerce Committee, the Subcommittee on Health and the Environment, and the Committee on Oversight and Government Reform

1:20 p.m.
Q and A

To learn more:

Bipartisan Deal Includes Important Step to Control Medicaid Drug Prices, But More Efforts Are Needed

Bipartisan Bill Would Increase Competition Among Drug Manufacturers and Lower Drug Prices

Trump Budget’s Prescription Drug Proposals Would Lower Patients’ Costs and Federal Spending; Some Could Lower Drug Prices

Getting to the Root of High Prescription Drug Prices

Getting to the Root of High Prescription Drug Prices: Drivers and Potential Solutions